S-((2R,6S,12S,13R,13AR,14AR,16AS)-14A-((CYCLOPROPYLSULFONYL)CARBAMOYL)-13-HYDROXY-6-(5-METHYLPYRAZINE-2-CARBOXAMIDO)-5,16-DIOXO-2-(PHENANTHRIDIN-6-YLOXY)OCTADECAHYDROCYCLOPROPA(E)PYRROLO(1,2-A)(1,4)DIAZACYCLOPENTADECIN-12-YL)-L-CYSTEINE
UNII 3YR6LQ2BCY
Substance Identification & Data
This profile provides standardized clinical and technical data for S-((2r,6s,12s,13r,13ar,14ar,16as)-14a-((cyclopropylsulfonyl)carbamoyl)-13-hydroxy-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)octadecahydrocyclopropa(e)pyrrolo(1,2-a)(1,4)diazacyclopentadecin-12-yl)-l-cysteine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3YR6LQ2BCY.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2205844-41-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C43H50N8O10S2 JIGNASPCIUXKGH-UQSTUKRTSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for S-((2r,6s,12s,13r,13ar,14ar,16as)-14a-((cyclopropylsulfonyl)carbamoyl)-13-hydroxy-6-(5-methylpyrazine-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)octadecahydrocyclopropa(e)pyrrolo(1,2-a)(1,4)diazacyclopentadecin-12-yl)-l-cysteine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.